In vivo evolution of carbapenem resistance in hypervirulent Klebsiella pneumoniae in a patient undergoing long-term treatment

J Antimicrob Chemother. 2022 Feb 2;77(2):531-533. doi: 10.1093/jac/dkab380.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Carbapenems / pharmacology
  • Carbapenems / therapeutic use
  • Humans
  • Klebsiella Infections* / drug therapy
  • Klebsiella pneumoniae* / genetics

Substances

  • Carbapenems